Divi's Laboratories Ltd - Company Profile
Powered by 
All the data and insights you need on Divi's Laboratories Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Divi's Laboratories Ltd Strategy Report
- Understand Divi's Laboratories Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Divi's Laboratories Ltd (Divi’s) is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs) and intermediates. The product portfolio includes a set of carotenoids such as Beta Carotene, Canthaxahnthin Astaxanthin, Lycopene, as well as other finished forms such as Vitamins (A, D3, D2, E Acetate and A Palmitate) and Lutein. The nutraceutical ingredients segment is involved in the production of active ingredient and finished forms of carotenoids. The company offers ingredient solutions in liquids, beadlets and powder forms. The company is involved in contract manufacturing of APIs and Intermediates for global innovator companies with through its custom synthesis segment. It operates manufacturing plants in Hyderabad and Visakhapatnam, India. Divi’s is headquartered in Hyderabad, Telangana, India.
Headquarters
India
Address
1-72/23(P)/Divis/303, , Divi Towers, Cyber Hills, Gachibowli, Hyderabad, Telangana, 500032
Website
www.divislabs.com
Telephone
91 40 23786300
No of Employees
16,950
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
DIVISLAB (NSE)
Revenue (2023)
$989.9M
-13.3%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
-38.4%
(2023 vs 2022)
Market Cap*
$11.7B
Net Profit Margin (2023)
XYZ
-29.0%
(2023 vs 2022)
* As of and is in US$
Divi's Laboratories Ltd premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Bupropion | Contract Research |
| Capecitabine | Custom Synthesis |
| Carbidopa | Exports |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Divi's Laboratories Ltd | Biocon Ltd | Piramal Enterprises Ltd | Jubilant Pharmova Ltd | Granules India Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Hyderabad | Bangalore | Mumbai | Noida | Hyderabad |
| State/Province | Telangana | Karnataka | Maharashtra | Uttar Pradesh | Telangana |
| No. of Employees | 16,950 | 3,408 | 12,220 | 1,034 | 3,650 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kiran S. Divi | Director; Chief Executive Officer | Executive Board | 2020 | - |
| Murali Krishna Prasad Divi, Ph.D. | Managing Director | Senior Management | 1990 | - |
| Ramesh B.V. Nimmagadda | Chairman | Non Executive Board | 2020 | - |
| N.V. Ramana | Executive Director | Executive Board | 1994 | - |
| Nilima Prasad Divi | Director - Commercial | Executive Board | 2012 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward